• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮唾液粘蛋白,即表层唾液酸糖蛋白,在再循环过程中被唾液酸化。

The epithelial sialomucin, episialin, is sialylated during recycling.

作者信息

Litvinov S V, Hilkens J

机构信息

Division of Tumor Biology, The Netherlands Cancer Institute (Antoni van Leeuwenhoekhuis, Amsterdam.

出版信息

J Biol Chem. 1993 Oct 5;268(28):21364-71.

PMID:8407976
Abstract

Episialin, the sialomucin encoded by the MUC1 gene is abundantly present at the surface of various epithelial cells. It is a transmembrane molecule that matures through several intermediate forms generated by proteolysis and sequential addition and processing of numerous O-linked glycans. Here we demonstrate that one of the biosynthetic intermediates, the premature form, which is incompletely glycosylated appears at the cell surface. By neuraminidase protection assays we show that cell surface-associated forms of episialin are constitutively internalized (0.9% of surface fraction/min) and recycled, with the intracellular residence time and total cycle time being approximately 66 and 143 min, respectively. During recycling, sialic acid residues are added to the premature form of episialin resulting in complete maturation of the molecule. Complete sialylation of episialin requires several rounds of recycling which continues after sialylation is apparently completed. The recycling of episialin may serve to achieve and maintain a high degree of sialylation.

摘要

Episialin是由MUC1基因编码的涎粘蛋白,大量存在于各种上皮细胞表面。它是一种跨膜分子,通过蛋白水解以及众多O-连接聚糖的依次添加和加工所产生的几种中间形式而成熟。在这里,我们证明了生物合成中间体之一,即糖基化不完全的早熟形式,出现在细胞表面。通过神经氨酸酶保护试验,我们表明Episialin与细胞表面相关的形式持续内化(每分钟表面部分的0.9%)并循环利用,细胞内停留时间和总循环时间分别约为66分钟和143分钟。在循环利用过程中,唾液酸残基被添加到Episialin的早熟形式中,导致分子完全成熟。Episialin的完全唾液酸化需要几轮循环利用,在唾液酸化明显完成后仍会继续。Episialin的循环利用可能有助于实现和维持高度的唾液酸化。

相似文献

1
The epithelial sialomucin, episialin, is sialylated during recycling.上皮唾液粘蛋白,即表层唾液酸糖蛋白,在再循环过程中被唾液酸化。
J Biol Chem. 1993 Oct 5;268(28):21364-71.
2
A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.一种由膜相关黏蛋白上皮涎蛋白/MUC1抑制E-钙黏蛋白介导的细胞间黏附的机制。
Mol Biol Cell. 1996 Apr;7(4):565-77. doi: 10.1091/mbc.7.4.565.
3
Suppression of cellular aggregation by high levels of episialin.高水平上皮涎蛋白对细胞聚集的抑制作用。
Cancer Res. 1992 Apr 15;52(8):2318-24.
4
Biosynthesis of MAM-6, an epithelial sialomucin. Evidence for involvement of a rare proteolytic cleavage step in the endoplasmic reticulum.
J Biol Chem. 1988 Mar 25;263(9):4215-22.
5
Alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl- glycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro.烷基溶血磷脂1-O-十八烷基-2-O-甲基甘油磷酸胆碱在体外通过上皮涎蛋白介导的E-钙黏蛋白中和作用诱导人乳腺MCF-7细胞侵袭。
Int J Cancer. 2001 May 15;92(4):527-36. doi: 10.1002/ijc.1216.
6
Selective reentry of recycling cell surface glycoproteins to the biosynthetic pathway in human hepatocarcinoma HepG2 cells.循环细胞表面糖蛋白在人肝癌HepG2细胞中选择性重新进入生物合成途径。
J Cell Biol. 1995 Aug;130(3):537-51. doi: 10.1083/jcb.130.3.537.
7
Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.唾液酸糖蛋白(MUC1)的过表达抑制整合素介导的细胞与细胞外基质成分的黏附。
J Cell Biol. 1995 Apr;129(1):255-65. doi: 10.1083/jcb.129.1.255.
8
Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction.唾液酸糖蛋白(MUC1)抑制细胞毒性淋巴细胞与靶细胞的相互作用。
J Immunol. 1993 Jul 15;151(2):767-76.
9
Biosynthesis of a tumor cell surface sialomucin. Maturation and effects of monensin.肿瘤细胞表面唾液酸黏蛋白的生物合成。莫能菌素的成熟及作用
J Biol Chem. 1988 Jul 15;263(20):9621-9.
10
Episialin acts as an antiadhesive factor in an in vitro model of human endometrial-blastocyst attachment.在人子宫内膜-胚泡附着的体外模型中,Episialin作为一种抗黏附因子发挥作用。
Biol Reprod. 2000 Jul;63(1):294-300. doi: 10.1095/biolreprod63.1.294.

引用本文的文献

1
Mucins as Precision Biomarkers in Glioma: Emerging Evidence for Their Potential in Biospecimen Analysis and Outcome Prediction.黏蛋白作为胶质瘤的精准生物标志物:其在生物样本分析和预后预测中潜力的新证据
Biomedicines. 2024 Dec 11;12(12):2806. doi: 10.3390/biomedicines12122806.
2
Irradiation Alters the Expression of MUC1, CD44 and Hyaluronan in Oral Mucosal Epithelium.辐射改变口腔黏膜上皮中MUC1、CD44和透明质酸的表达。
Biomedicines. 2022 Nov 4;10(11):2816. doi: 10.3390/biomedicines10112816.
3
Global view of human protein glycosylation pathways and functions.
人类蛋白糖基化途径和功能的全球视图。
Nat Rev Mol Cell Biol. 2020 Dec;21(12):729-749. doi: 10.1038/s41580-020-00294-x. Epub 2020 Oct 21.
4
Sequence-Specific Mucins for Glycocalyx Engineering.用于糖萼工程的序列特异性黏蛋白。
ACS Synth Biol. 2019 Oct 18;8(10):2315-2326. doi: 10.1021/acssynbio.9b00127. Epub 2019 Oct 2.
5
CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth.嵌合抗原受体 T 细胞靶向肿瘤 MUC1 糖蛋白可减少三阴性乳腺癌的生长。
Front Immunol. 2019 May 24;10:1149. doi: 10.3389/fimmu.2019.01149. eCollection 2019.
6
Neuraminidase 1-mediated desialylation of the mucin 1 ectodomain releases a decoy receptor that protects against lung infection.神经氨酸酶 1 介导的黏蛋白 1 胞外结构域去唾液酸化释放一种诱饵受体,可防止肺部感染。
J Biol Chem. 2019 Jan 11;294(2):662-678. doi: 10.1074/jbc.RA118.006022. Epub 2018 Nov 14.
7
Genetically Encoded Toolbox for Glycocalyx Engineering: Tunable Control of Cell Adhesion, Survival, and Cancer Cell Behaviors.用于糖萼工程的基因编码工具箱:对细胞黏附、存活和癌细胞行为的可调控制
ACS Biomater Sci Eng. 2018 Feb 12;4(2):388-399. doi: 10.1021/acsbiomaterials.7b00037. Epub 2017 Feb 28.
8
Autophagy is decreased in triple-negative breast carcinoma involving likely the MUC1-EGFR-NEU1 signalling pathway.自噬在三阴性乳腺癌中减少,这可能涉及MUC1-表皮生长因子受体-NEU1信号通路。
Int J Clin Exp Pathol. 2015 May 1;8(5):4344-55. eCollection 2015.
9
MUC1-mediated motility in breast cancer: a review highlighting the role of the MUC1/ICAM-1/Src signaling triad.MUC1介导的乳腺癌细胞运动性:一篇强调MUC1/细胞间黏附分子-1/原癌基因酪氨酸蛋白激酶Src信号三联体作用的综述
Clin Exp Metastasis. 2015 Apr;32(4):393-403. doi: 10.1007/s10585-015-9711-8. Epub 2015 Mar 11.
10
Altered Mucins (MUC) trafficking in benign and malignant conditions.良性和恶性疾病中黏蛋白(MUC)转运的改变
Oncotarget. 2014 Sep 15;5(17):7272-84. doi: 10.18632/oncotarget.2370.